Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Annual Meeting Talks

Sign in to view content

Sign in

Number of Injections and Time to Dry Analysis of Brolucizumab Versus Aflibercept in Patients With Neovascular AMD: 96-Week Data From HAWK and HARRIER

  • Carl D. Regillo, MD
  • Video
  • Published 2020

Related

  • Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

    Charles C Wykoff, MD, PhD, FASRS

    Updates from the Field

    2021

  • Abicipar for nAMD Provides Faster Retinal Fluid Resolution, and Achieved Similar Dryness Through Week 104 With Fewer Injections

    Nancy M. Holekamp, MD, FASRS

    Annual Meeting Talks

    2020

  • Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study

    Ananda Kalevar, MD, FRCS(C), DABO

    On Demand Cases, Courses, and Papers

    2020

Category: AMD-Neovascular

  • Aflibercept
  • Sustained retinal dryness
  • Injection number
  • Treatment burden

See more

  • Annual Meeting Talks
  • Carl D. Regillo, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2022 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.